Manufacturer record
Sresan Pharmaceutical Manufacturer: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
9 batches manufactured by Sresan Pharmaceutical Manufacturer (Karnataka) were declared Not of Standard Quality between October 2025 and February 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: INT-01, Ondansetron Hydrochloride Oral Solution IP (exp Mar 2027). DTL, Bengaluru, Karnataka (state lab) found it not of standard quality: Test for pH. Listed in the February 2026 alert.
Records by type
9 records linked to Sresan Pharmaceutical Manufacturer in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ondansetron Hydrochloride Oral Solution IP | Batch INT-01Mfg Apr 2025 · Exp Mar 2027 | Test for pHpH | DTL, Bengaluru, KarnatakaState lab | Feb 2026 |
| Aceclofenac and Paracetamol Tablets | Batch INT-02Mfg Apr 2025 · Exp Mar 2028 | Test for Uniformity of Weight, Assay for Paracetamol and AceclofenacAssay | DTL, Bengaluru, KarnatakaState lab | Feb 2026 |
| Levocetirizine DiHydrochloride, Montelukast | Batch SRT-034Mfg Feb 2024 · Exp Jan 2026 | DescriptionDescription | SDT&RL, BhubaneswarState lab | Jan 2026 |
| (Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride and Chlorpheniramine Maleate Syrup)(Respolite-D) | Batch SR 080Mfg Dec 2024 · Exp Nov 2026 | ContentOther | Drugs Testing Laboratory, Madurai-19State lab | Dec 2025 |
| Terbutaline Sulphate, Ambroxol Hydrochloride & Choline Theophylinate | Batch SR-10Mfg May 2025 · Exp Apr 2028 | ContentOther | Drugs Testing Laboratory, Chennai-06State lab | Nov 2025 |
| Ranitidine Oral Solution IP | Batch SR-017Mfg Jun 2024 · Exp May 2026 | This particular batch of sample fails the test Assay of Ranitidine.Assay | RDTL ErnakulamState lab | Nov 2025 |
| Cyproheptadine Hydrochloride Syrup IP | Batch SR-086Mfg Dec 2024 · Exp Nov 2026 | The smple fails in the test PH and AssayAssay | RDTL ErnakulamState lab | Nov 2025 |
| Cyproheptadine Hydrochloride Syrup | Batch SR-46Mfg Aug 2025 · Exp Jul 2027 | pHpH | Drugs Testing Laboratory, Chennai-06State lab | Nov 2025 |
| Coldrif Syrup (Paracetamol, Phenylephrine Hydrochloride, Chlorpheniramine Syrup) | Batch SR-13Mfg May 2025 · Exp Apr 2027 | AdulteratedAdulterated | Drugs Testing Laboratory, Chennai-06State lab | Oct 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.